| Hang Seng China Enterprises | 89.360 HKD | -0.920 | -1.019% | 161.87M | 14.50B | 86.975 (+2.742%) HKD as at 2025/02/25 | | |
| Hang Seng Index | 24.260 HKD | -0.200 | -0.818% | 465.26M | 11.30B | 23.260 (+4.300%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.150 HKD | -0.095 | -1.811% | 2.00B | 10.28B | 5.580 (-7.709%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.986 HKD | -0.199 | -3.838% | 279.71M | 1.40B | 6.590 (-24.340%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.782 HKD | +0.062 | +3.605% | 543.60M | 966.14M | 1.831 (-2.697%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 11.050 HKD | -0.170 | -1.515% | 36.52M | 402.18M | 12.133 (-8.924%) HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.270 HKD | +0.034 | +1.521% | 166.23M | 375.91M | 2.726 (-16.725%) HKD as at 2025/02/25 | | |
| London Gold Fixing Price | 2,469.000 HKD | +51.000 | +2.109% | 80.93K | 200.69M | N/A | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.195 HKD | -0.085 | -1.610% | 34.53M | 180.01M | 5.000 (+3.906%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.210 HKD | -0.110 | -2.068% | 22.08M | 115.27M | 5.659 (-7.926%) HKD as at 2025/02/25 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 14.060 HKD | -0.300 | -2.089% | 6.73M | 94.93M | 10.297 (+36.542%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.960 HKD | +0.740 | +4.297% | 4.24M | 76.43M | 13.980 (+28.473%) HKD as at 2025/02/24 | | |
| Hang Seng China Enterprises | 10.530 HKD | -0.070 | -0.660% | 5.72M | 60.32M | 10.808 (-2.575%) HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 4.426 HKD | +0.054 | +1.235% | 12.30M | 54.76M | 4.925 (-10.137%) HKD as at 2025/02/24 | | |
| CSI 300 | 43.780 HKD | -0.020 | -0.046% | 1.15M | 50.24M | 43.473 (+0.706%) HKD as at 2025/02/25 | | |
| FTSE China A50 | 14.080 HKD | -0.030 | -0.213% | 2.47M | 34.69M | 13.749 (+2.407%) HKD as at 2025/02/24 | | |
| FTSE China A50 | 13.120 HKD | 0.000 | 0.000% | 2.03M | 26.59M | 12.681 (+3.459%) HKD as at 2025/02/25 | | |
| S&P GSCI Crude Oil Index Excess Return | 6.970 HKD | +0.375 | +5.686% | 2.92M | 20.81M | 6.880 (+1.316%) HKD as at 2025/02/24 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.020 HKD | -0.280 | -2.105% | 1.49M | 19.10M | 11.063 (+17.692%) HKD as at 2025/02/25 | | |
| Hang Seng High Dividend Yield | 27.760 HKD | +0.300 | +1.092% | 656.59K | 18.18M | 24.714 (+12.325%) HKD as at 2025/02/24 | | |
| CSI Hong Kong Dividend | 36.840 HKD | +0.120 | +0.327% | 464.41K | 17.14M | 32.341 (+13.910%) HKD as at 2025/02/25 | | |
| FTSE US Treasury 20+ Years Index | 68.700 HKD | +0.600 | +0.881% | 230.72K | 15.90M | 70.043 (-1.917%) HKD as at 2025/02/24 | | |
| CSI 300 | 28.180 HKD | -0.200 | -0.705% | 487.70K | 13.78M | 28.366 (-0.654%) HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 63.280 HKD | +0.660 | +1.054% | 205.85K | 13.17M | 67.238 (-5.886%) HKD as at 2025/02/25 | | |
| London Gold Fixing Price | 81.200 HKD | +1.840 | +2.319% | 160.77K | 13.08M | 69.203 (+17.336%) HKD as at 2025/02/25 | | |
| CSI 300 | 40.020 CNY | -0.180 | -0.448% | 287.60K | 11.53M | 40.598 (-1.424%) CNY as at 2025/02/25 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.800 HKD | +0.032 | +0.849% | 2.69M | 10.21M | 4.098 (-7.281%) HKD as at 2025/02/25 | | |
| FTSE China A50 | 12.000 CNY | -0.050 | -0.415% | 850.34K | 10.18M | 11.844 (+1.315%) CNY as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 25.000 HKD | -0.320 | -1.264% | 404.70K | 10.04M | 25.595 (-2.325%) HKD as at 2025/02/24 | | |
| MSCI India Net Total Return (USD) Index | 7.055 HKD | -0.140 | -1.946% | 1.43M | 10.00M | 6.278 (+12.386%) HKD as at 2025/02/24 | | |